XTAI
1713
Market cap212mUSD
Oct 08, Last price
44.95TWD
1D
0.45%
1Q
-6.06%
Jan 2017
201.68%
Name
Cathay Chemical Works Inc
Chart & performance
P/E
11.62
P/S
14.75
EPS
3.87
Div yield, %
16.69%
Shrs. gr., 5y
0.06%
Rev. gr., 5y
-0.66%
Revenues
460m
-12.87%
Net income
584m
-62.48%
CFO
121m
-23.14%
Dividend
Aug 06, 20263.1 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cathay Chemical Works Inc. manufactures and sells specialty and fine chemicals under the CATHAY brand in Taiwan. It provides sodium formaldehyde sulfoxylate, sodium metabisulfite, zinc oxide, calcined zinc oxide, sodium hydrosulfite, zinc dust, and sodium hydroxymethanesulfinate, as well as galvanized metal and steel sheets. The company exports its products to Asia, Europe, America, New Zealand, and Australia. Cathay Chemical Works Inc. was founded in 1962 and is based in Taipei, Taiwan.
Key people
Jou-Er Ing
Chairman of the Board · since 2020
Geng-Sheng Jin
Deputy General Manager · since 2017
Chi-Ming Hou
Head of Factory · since 2017
Jin-Hua Hsu
Head of Accounting · since 2005
C.C. Hung
General Manager, Head of Finance, Corporate Governance Officer, Director · since 2023
Wen-Kuei Chi
Independent Director · since 2023
Chi-Ying Tseng
Independent Director · since 2023
Lien-Chu Yeh
Independent Director · since 2023
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||